One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-145920
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 5 |
Affiliation: University of Oxford, Medical College of Wisconsin, Centre d'Investigation Clinique de Nantes, Centre Hospitalier Universitaire de Nantes, Nantes Université, Inserm, LMU Klinikum, Ludwig-Maximilians-Universität München, St. James's Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Mayo Clinic, Sir Charles Gairdner Hospital, Linear Clinical Research, Virginia Cancer Specialists, Willamette Valley Cancer Institute and Research Center, Rocky Mountain Cancer Centers, Loxo Oncology at Lilly (United States), The University of Texas MD Anderson Cancer CenterBRUIN MCL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
